Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes

Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2

(2017) Denis Comte et al.   Arthritis & Rheumatology

CD3+CD8+CD28−T Lymphocytes in Patients with Lupus Nephritis

(2016) Marcelina Żabińska et al.   Journal of Immunology Research

Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients

(2015) M F Ugarte-Gil et al.   LUPUS

The Pathology of T Cells in Systemic Lupus Erythematosus

(2014) Anselm Mak et al.   Journal of Immunology Research

Baseline Numbers of Circulating CD28-negative T Cells May Predict Clinical Response to Abatacept in Patients with Rheumatoid Arthritis

(2011) MIRKO SCARSI et al.   JOURNAL OF RHEUMATOLOGY

Measures of adult systemic lupus erythematosus: Updated Version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questi

(2011) Juanita Romero-Diaz et al.   ARTHRITIS CARE & RESEARCH

CD8+CD28−, suppressive T cells in systemic lupus erythematosus

(2008) A Tulunay et al.   LUPUS